Oncology highlights from AACR 2026
The VJOncology podcast presents highlights from the AACR 2026 meeting, focusing on immuno-oncology and targeted therapy. Experts discuss clinical challenges with checkpoint inhibitors, PLN-101095 in solid tumors, denikitug safety and activity, and elisrasib for KRAS G12C-mutant…